Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05557604
PHASE2
Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer
Sponsor: Regina Elena Cancer Institute
View on ClinicalTrials.gov
Summary
This is a prospective, open, randomized phase II trial.
Official title: Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer (STUNNIN): A Randomized Phase II Study
Key Details
Gender
MALE
Age Range
18 Years - 90 Years
Study Type
INTERVENTIONAL
Enrollment
146
Start Date
2021-02-02
Completion Date
2027-02-02
Last Updated
2022-09-28
Healthy Volunteers
No
Conditions
Interventions
DRUG
Decapeptyl
STAD androgen deprivation
Locations (3)
Ifo Regina elena
Rome, Lazio, Italy
ifo Regina Elena
Rome, RM, Italy
Regina Elena National Cancer Institute
Rome, Italy